Ardelyx Inc.
34175 Ardenwood Boulevard
Suite 100
Fremont
California
94555
United States
Tel: 510-745-1700
Website: http://www.ardelyx.com/
263 articles about Ardelyx Inc.
-
Ardelyx Reports Positive Clinical Results Of RDX022 For The Treatment Of Hyperkalemia
1/5/2016
-
Ardelyx Strengthens Executive Leadership Team With The Appointment Of Paul Korner, MD, MBA, As Executive Vice President And Chief Medical Officer
1/4/2016
-
Ardelyx Reports Third Quarter 2015 Financial Results
11/12/2015
-
Ardelyx To Report Third Quarter 2015 Financial Results On November 12, 2015
10/30/2015
-
Ardelyx Announces Upcoming Presentations For Tenapanor At The American Society of Nephrology's Kidney Week Meeting 2015
10/28/2015
-
Ardelyx Appoints William Bertrand, Jr. To Its Board Of Directors
10/27/2015
-
Ardelyx To Present Phase 2 Data For Tenapanor In IBS-C Patients At The 2015 American College of Gastroenterology Annual Meeting
10/9/2015
-
Sanofi Terminates a $200 Million NaP2b Development Deal With Ardelyx
9/3/2015
-
Ardelyx Reports Second Quarter 2015 Financial Results
8/12/2015
-
Ardelyx To Report Second Quarter 2015 Financial Results On August 12, 2015
8/6/2015
-
Ardelyx To Present At The 2015 Wedbush PacGrow Healthcare Conference
8/5/2015
-
Ardelyx To Provide Updates On Research And Development Programs At Today's Inaugural R&D Day In New York City
7/14/2015
-
Ardelyx To Host Inaugural R&D Investor Day In New York City On July 14, 2015
6/30/2015
-
Ardelyx To Present At The 2015 JMP Securities Life Sciences Conference
6/17/2015
-
Bay Area's Ardelyx Will Go It Alone on GI Drug As it Splits With AstraZeneca PLC
6/4/2015
-
Ardelyx Inc. Presents Positive Results From Its Phase 2b Clinical Trial Evaluating Tenapanor In IBS-C Patients At Digestive Disease Week 2015
5/20/2015
-
Ardelyx Inc. Reports First Quarter 2015 Financial Results
5/13/2015
-
Ardelyx Inc. Reports Results From Phase 2a Clinical Trial Evaluating Tenapanor In Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus And Albuminuria
5/6/2015
-
Ardelyx Inc. Appoints Dr. Annalisa Jenkins To Its Board Of Directors
4/20/2015
-
Ardelyx Inc. To Present At The 22nd Annual Future Leaders In The Biotech Industry Conference
3/13/2015